Protocol to study the immune profile of syngeneic mouse tumor models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protocol to study the immune profile of syngeneic mouse tumor models

Published:2024-09 Issue:3 Volume:5 Page:103139
ISSN:2666-1667
Container-title:STAR Protocols
language:en
Short-container-title:STAR Protocols

Author:

Miyauchi Sayuri,Arimoto Kei-ichiro,Liu Mengdan,Zhang Yue,Zhang Dong-Er^ORCID

Funder

NIH

Publisher

Elsevier BV

Reference20 articles.

1. Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18;Miyauchi;Cell Rep.,2023

2. The loss of RNA N(6)-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8(+) T cell dysfunction and tumor growth;Dong;Cancer Cell,2021

3. Long-lasting mRNA-encoded interleukin-2 restores CD8(+) T cell neoantigen immunity in MHC class I-deficient cancers;Beck;Cancer Cell,2024

4. The tumor suppressor kinase DAPK3 drives tumor-intrinsic immunity through the STING-IFN-beta pathway;Takahashi;Nat. Immunol.,2021

5. Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice;Chinnasamy;J. Clin. Invest.,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3